haNK

natural killer cell line · ImmunityBio, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for haNK, covering 2024-08-09 to 2024-11-20. Get the full timeline:

Most recent: Clinical Trial Update: QUILT-3.028: Study of haNK™ for Infusion in Subjects With Metastatic or Locally Advanced Solid Tumors [Phase 1]